Inner Mongolia Duhe Innovation R&D Technology Development Co., Ltd. is a chemical, biomedicine high-tech enterprise integrating R & D and production. The company relies on the advanced technologies of Inner Mongolia University, Shanghai Institute of Organic Chemistry of Chinese Academy of Sciences, China Academy of Traditional Chinese Medicine, Inner Mongolia Academy of Science and Technology and other universities and scientific research institutes., we are committed to the research and development and application of innovative drugs and targeted anticancer drugs. 
The company's R & D team is led by Dr. Liu Guodu, a young leader of the "Grassland Talent" in the Inner Mongolia Autonomous Region. It has the world's leading unnatural amino acids with independent intellectual property rights, antibody drug conjugates amanitin Payloads and asymmetric catalytic synthesis technology. There are more than 20 high-level talents with doctoral and master's technical backbones. They have authorized 16 China invention patents, 3 South African invention patents, 1 U.S. invention patent, 4 PCT patents, 30 China invention patents, and applied for 3 U.S. invention patents. 
"Directly hit the forefront of the world and monopolize the international leader", since its establishment, Duhe Creative Research has always adhered to the forefront of pharmaceutical research and development, committed to the research and development and production of innovative and internationally competitive raw materials and innovative pharmaceutical products, becoming the world's leading innovative pharmaceutical company.
About us
Payload,amanitin,Antibody-Drug Conjugate (ADC),Peptide intermediates, chemical synthesis,unnatural amino acid
Liu Guodu, Doctor. Distinguished researcher, doctoral supervisor, and project leader of the "Horse Project" of Inner Mongolia University. Founder, chairman and legal person of Inner Mongolia Duhe Chuangyan Technology Development Co., Ltd. Dr. Liu Guodu has been deeply engaged in the design and synthesis of organic small molecule catalysts, metal-catalyzed asymmetric synthesis, total synthesis of complex natural products and medicinal chemistry for more than 10 years, with outstanding results. Completed the full synthesis of more than 20 complex natural products and active molecules such as α-Amanitin, and carried out world-leading research on the development of new anti-cancer drugs targeted by ADCs. Hosted 14 projects such as National Nature, with a total funding of> 12 million yuan. Key participants participated in 11 national natural key projects and NIH projects in the United States, with a total funding of more than 75 million yuan. Published more than 30 academic SCI papers,
Born in 1994, he holds a master's degree in chemistry from Inner Mongolia University.  He has worked in many enterprises such as East China Normal University and Ningbo Zejun Pharmaceutical, and has rich experience and attainments in the field of organic synthesis. He has participated in more than 10 important research and development projects and achieved many significant achievements.
Liu Guodu, Doctor. Distinguished researcher, doctoral supervisor, and project leader of the "Horse Project" of Inner Mongolia University. Founder, chairman and legal person of Inner Mongolia Duhe Chuangyan Technology Development Co., Ltd. Dr. Liu Guodu has been deeply engaged in the design and synthesis of organic small molecule catalysts, metal-catalyzed asymmetric synthesis, total synthesis of complex natural products and medicinal chemistry for more than 10 years, with outstanding results. Completed the full synthesis of more than 20 complex natural products and active molecules such as α-Amanitin, and carried out world-leading research on the development of new anti-cancer drugs targeted by ADCs. Hosted 14 projects such as National Nature, with a total funding of> 12 million yuan. Key participants participated in 11 national natural key projects and NIH projects in the United States, with a total funding of more than 75 million yuan. Published more than 30 academic SCI papers,
He is a co- founding partner of the company, and concurrently serves as a director and supervisor of various companies. Former vice president of JD Investment, and very experienced in corporate investment, operation and management in biomedicine, industrial manufacturing, consumer goods and other industries.
Responsible for investment and financing management.
<
>
Core Team
The company presently has more than 20 employees, including 15 R&D personnel, and > 50% of those with master's degree or above.
Patent for Invention
Enterprise culture
  • Enterprise vision
    "Directly hit the world's frontiers and dominate the world's top spot", create an international-level innovative technology platform for pharmaceutical research and development, serve global customers, and become the world's leading innovative drug research and development and production enterprise.
  • Enterprise mission
    Focus on technology and innovation-driven, overcome problems in the field of drug synthesis and provide customers with more effective and safer high-quality innovative drugs.
  • Enterprise values
    Innovation-driven, pursuit of excellence, customer first, win-win cooperation, responsibility.